{"filing":{"accession_number":"0001213900-26-111243","cik":"0001897532","ticker":"PASW","company_name":"Ping An Biomedical Co., Ltd.","form":"6-K","filing_date":"2026-10-21","report_date":"2026-10-21","primary_document":"ea0306132-6k_pingan.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1897532/000121390026111243/ea0306132-6k_pingan.htm"},"events":[{"id":36661,"run_id":33805,"accession_number":"0001213900-26-111243","anchor_item_number":"EX-99.1","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"This press release announces a 1-for-40 reverse stock split of Ping An Biomedical's Class A and Class B ordinary shares, effective October 23, 2026. The reverse split is a governance and capital structure event approved by the board on August 6, 2026, and previously authorized by shareholders at an extraordinary general meeting on March 18, 2026. While reverse splits are sometimes routine, this one materially affects share count (from ~112.9M to ~2.8M Class A shares) and par value, and would affect a reasonable investor's assessment of the company's capital structure and share valuation metrics.","company_name":"Ping An Biomedical Co., Ltd.","ticker":"PASW","filing_date":"2026-10-21","form":"6-K","submitted_at":null,"items":[{"id":41160,"accession_number":"0001213900-26-111243","item_number":"EX-99.1","item_title":"ea030613201ex99-1.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This press release announces a 1-for-40 reverse stock split of Ping An Biomedical's Class A and Class B ordinary shares, effective October 23, 2026. The reverse split is a governance and capital structure event approved by the board on August 6, 2026, and previously authorized by shareholders at an extraordinary general meeting on March 18, 2026. While reverse splits are sometimes routine, this one materially affects share count (from ~112.9M to ~2.8M Class A shares) and par value, and would affect a reasonable investor's assessment of the company's capital structure and share valuation metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T15:00:42.838324+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":41160,"accession_number":"0001213900-26-111243","item_number":"EX-99.1","item_title":"ea030613201ex99-1.htm","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"This press release announces a 1-for-40 reverse stock split of Ping An Biomedical's Class A and Class B ordinary shares, effective October 23, 2026. The reverse split is a governance and capital structure event approved by the board on August 6, 2026, and previously authorized by shareholders at an extraordinary general meeting on March 18, 2026. While reverse splits are sometimes routine, this one materially affects share count (from ~112.9M to ~2.8M Class A shares) and par value, and would affect a reasonable investor's assessment of the company's capital structure and share valuation metrics.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-10-21T15:00:42.838324+00:00","company_name":"Ping An Biomedical Co., Ltd.","ticker":"PASW","filing_date":"2026-10-21"}]}